1. Merger of Rotman's and their revenues 2. No Convertible Debt on books 3. Massive Insider buying (per Form 4 filings) 4. Recent Institutional Investment of $200k at .15 5. New European Patents 6. Possible buyback of shares by the company 7. Possible EMA share buyback (pending judge's response to lawsuit)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.